ANZCHOG has awarded funding to progress five new clinical trial concepts.
ANZCHOG's Concept Development Workshops enables researchers from across Australia and New Zealand to come together to discuss and develop new clinical trial ideas.
This year, we have funded more applications than ever before....
The successful applications were:
- Bright light therapy to improve sleep, reduce fatigue and improve the quality of life in children with acute lymphoblastic leukaemia during maintenance treatment: Dr Lisa Walter The Ritchie Centre, Hudson Institute of Medical Research, Victoria
- Low dose histone deactlyase inhibitors (HDACi) as differentiating agents in recurrent and refractory solid tumours of childhood; A phase II study Dr. Paul Wood, Children’s Cancer Centre, Monash Medical Centre, Victoria
- Used prior to the administration of chemotherapy, can a comprehensive patient assessment tool improve process and clinical outcomes for children with cancer? Rachel Edwards, Lady Cilento Children’s Hospital, Queensland
- Individualised pharmacokinetics of once daily intravenous busulfan in paediatric patients undergoing haematopoietic stem cell transplantation” Dr. Richard Mitchell, Sydney Children’s Hospital, NSW
- Comparative study of 6-mecaptopurine (6MP) metabolite levels and liver toxicity in patients with Acute Lymphoblastic Leukaemia <18 years of age following either Children’s Oncology Group (COG) or Berlin-Frankfurt-Munster (BFM) style maintenance therapy: Dr. Siobhan Cross, Children’s Haematology Oncology Centre, Christchurch NZ
These workshops will be held within the next six months and we look forward to continuing to support our members to build a national, clinical trial portfolio of studies/